https://www.prnewswire.com/news-releases/rational-vaccines-announces-a-clinical-trial-to-determine-baseline-characteristics-of-patients-diagnosed-with-recurrent-symptomatic-herpes-simplex-type--2-hsv-2-virus-301605324.html
0
0
46 words
0
Comments
/PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the...
You are the first to view
Create an account or login to join the discussion